Financial Performance Highlights

Q2 FY27 Performance (YoY Comparison)

  • Revenue from operations: ₹5,480.2 million, up 23.2% from ₹4,448.0 million in Q2 FY26
  • Other income: ₹81.3 million, decreased 0.8% from ₹82.0 million
  • Total income: ₹5,561.5 million, increased 22.8% from ₹4,529.9 million
  • Cost of materials consumed: ₹737.7 million, increased 18.6% from ₹622.1 million
  • Employee benefits expense: ₹751.8 million, increased 27.9% from ₹587.8 million
  • Finance costs: ₹220.0 million, increased 16.7% from ₹188.5 million
  • Depreciation and amortization: ₹446.1 million, increased 24.5% from ₹358.4 million
  • Professional fees to doctors: ₹1,403.0 million, increased 32.0% from ₹1,063.2 million
  • Other expenses: ₹888.0 million, increased 29.4% from ₹686.2 million
  • Profit before tax: ₹1,115.0 million, increased 8.9% from ₹1,023.7 million
  • Current tax: ₹332.2 million, increased 13.5% from ₹292.6 million
  • Deferred tax expense/(credit): -₹56.1 million, increased 122.7% from -₹25.2 million
  • Total tax expense: ₹276.1 million, increased 3.2% from ₹267.5 million
  • Profit for the year: ₹838.9 million, increased 10.9% from ₹756.2 million
  • EBITDA (Post Ind AS 116 & excluding other income): ₹1,699.8 million, increased 14.2% from ₹1,488.7 million
  • IND AS Impact: ₹275.5 million, increased 18.0% from ₹233.5 million
  • EBITDA (Pre Ind AS 116 & excluding other income): ₹1,424.3 million, increased 13.5% from ₹1,255.1 million

Q2 FY27 Performance (QoQ Comparison)

  • Revenue from operations: Increased 16.6% from ₹4,699.9 million in Q1 FY27
  • Other income: Decreased 36.1% from ₹127.1 million
  • Total income: Increased 15.2% from ₹4,827.0 million
  • Profit before tax: Increased 32.8% from ₹839.5 million
  • Profit for the year: Increased 34.1% from ₹625.4 million
  • EBITDA (Post Ind AS 116): Increased 26.2% from ₹1,346.5 million

H1 FY27 Performance (YoY Comparison)

  • Revenue from operations: ₹10,180.1 million, increased 27.6% from ₹7,977.3 million in H1 FY26
  • Other income: ₹208.4 million, decreased 26.1% from ₹282.1 million
  • Total income: ₹10,388.4 million, increased 25.8% from ₹8,259.4 million
  • Profit before tax: ₹1,954.6 million, increased 12.5% from ₹1,737.4 million
  • Profit for the year: ₹1,464.3 million, increased 13.1% from ₹1,294.3 million
  • EBITDA (Post Ind AS 116): ₹3,046.3 million, increased 20.6% from ₹2,524.9 million
  • EBITDA (Pre Ind AS 116): ₹2,506.5 million, increased 21.2% from ₹2,067.3 million

Operational Performance Metrics

Hospital Classification and Performance

Mature Hospitals (14 hospitals, completed 5+ years of operations):

  • Contribution: 73% of group revenue, 63% of group beds
  • Q2 FY27 Occupancy: 54%
  • Q2 FY27 EBITDA Margin: 28%
  • ARPOB: ₹67,000
  • Locations: Banjara, Secunderabad, LB Nagar, Hydernagar, Kondapur, Vijayawada, Marathahalli, BG Road, Madhukar, Guindy, Rosewalk, RCHI, Hebbal, Vizag

Emerging Hospitals (7 hospitals, 2-5 years of operations):

  • Contribution: 22% of group revenue, 25% of group beds
  • Q2 FY27 Occupancy: 47%
  • Q2 FY27 EBITDA Margin: 26%
  • ARPOB: ₹59,000
  • Locations: OMR, Financial District, Himayat Nagar, Sarjapur, Anna Nagar, Warangal, Guwahati

New Hospitals (5 hospitals, 0-2 years of operations):

  • Contribution: 4% of group revenue, 12% of group beds
  • Q2 FY27 Occupancy: 27%
  • Q2 FY27 EBITDA Margin: -16%
  • ARPOB: ₹43,000
  • Locations: Rajahmundry, Electronic City, HRBR, Nellore, Guntur

Group Level Operational Metrics

  • Total hospitals: 26
  • Q2 FY27 Group Occupancy: 49%
  • Q2 FY27 Group EBITDA Margin: 26%
  • Group ARPOB: ₹63,000

Capacity Expansion and New Commencements

  • Rainbow Nellore: 70 capacity beds, 55 operational beds, commenced September 1, 2026
  • Rainbow Guntur: 50 capacity beds, 40 operational beds, commenced September 1, 2026
  • Rainbow HRBR: 60 capacity beds, 48 operational beds, commenced May 1, 2026

Business Model and Strategy

  • Hub and Spoke approach: Integrated care where obstetric and Pediatric teams work together
  • Regional 'South Connect' model: Regional spokes 200-250 km from city hubs in tier-II cities
  • Doctor engagement model: Doctors work exclusively on full-time, retainer basis with 24/7 commitment
  • Service coverage: Pediatric services under "Rainbow Children's Hospital" brand, women's healthcare under "BirthRight by Rainbow" brand

Current Network Status

  • 26 hospitals, 6 clinics, 2 dedicated fertility clinics across 11 cities
  • Total bed capacity: 2,685 beds (includes 130 beds at Madhukar hospital where medical services are provided)
  • Operates country's largest pediatric DNB training programme in private healthcare

Institutional Shareholding (as of September 30, 2026)

Top institutional shareholders holding more than 1%:

  • ICICI Prudential & ISIF Equity Fund: 5.5%
  • DSP Mutual Fund: 3.4%
  • Franklin Templeton Investment Funds: 2.3%
  • HDFC Life Insurance Company: 2.1%
  • Abu Dhabi Investment Authority: 2.1%
  • Vanguard Fund: 2.0%
  • Tata Mutual Fund: 1.9%
  • Axis Mutual Fund: 1.6%
  • Nippon Mutual Fund: 1.6%
  • Ashoka Whiteoak / Ashoka India: 1.5%
  • Motilal Oswal Mutual Fund: 1.5%

Future Expansion Plans

  • Coimbatore: Expected commissioning by H2 FY27-28
  • Indore: Currently operating 25 beds, ~100 beds independent facility likely by end of FY29
  • Mumbai: Hospital likely to commence by Q1 FY28

Key Personnel

  • Dr. Ramesh Kancharla: Chairman & Managing Director
  • Shreya Mitra: Company Secretary and Compliance Officer
  • Saurabh Bhandari: Head Investor Relations & Group Business Analyst
  • Sudarshan Patodia: Group Chief Financial Officer